Engineered Microbial Partnership for Efficient Isopropanol Production at High Yields and Selectivity with CO2 Fixation

This technology provides a sustainable and efficient alternative to traditional IPA production methods by leveraging the natural capabilities of a microbial partnership.

Technology

The production of isopropanol (IPA) has traditionally depended on petroleum-based methods, which are not only energy-intensive but also contribute significantly to greenhouse gas emissions. As industries seek sustainable alternatives, the focus has shifted towards biological methods that utilize renewable resources. A microbial partnership offers a promising solution by leveraging the natural interactions between different microbial species to enhance metabolic processes. UD Researchers have created a process that uses external CO2 and biomass-derived materials, employing engineered strains of Clostridium acetobutylicum (Cac) and Clostridium ljungdahlii (Clj) to exchange cellular materials and maintain metabolic stability. This technology centers on a microbial partnership where Cac and Clj directly exchange materials, boosting IPA production. Cac is genetically modified to focus on acetone production by altering its metabolic pathway with CRISPR/Cas9. Clj uses the Wood-Ljungdahl pathway to assimilate CO2 and H2. The engineered Cac strain, with acetone pathway genes, produces up to 125 mM of acetone. When cultured with Clj, it achieves high IPA production selectivity (2.5 mol IPA/mol EtOH) through interspecies electron transfer, reaching IPA levels above 200 mM and carbon recovery up to 94.5%, which is impossible by conventional fermentation using a single microbial strain. This technology provides a sustainable and efficient alternative to traditional IPA production methods by leveraging the natural capabilities of a microbial partnership. By significantly reducing the reliance on petroleum-based feedstocks and minimizing greenhouse gas emissions, this approach not only addresses environmental concerns but also offers economic advantages through lower energy requirements and higher product yields. The robust and stable nature of the engineered microbial consortium ensures consistent performance, making it an attractive solution for industries seeking to transition towards greener and more sustainable production processes.

Benefits

  • Achieves high selectivity and yield in IPA production
  • Enhances CO2 fixation and carbon recovery
  • Maintains a robust microbial consortium with stable metabolic interactions
  • Reduces reliance on petroleum-based processes, lowering energy input and CO2 emissions

Applications

  • Biofuel production with reduced environmental impact
  • Sustainable chemical manufacturing
  • Large-scale fermentation processes for industrial biotechnology